# Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases

> **NCT00001723** · PHASE2 · COMPLETED · sponsor: **Jack Yanovski** · enrollment: 200 (actual)

## Conditions studied

- Diabetes Mellitus
- Hypertension
- Metabolic Disease
- Obesity
- Sleep Apnea Syndrome

## Interventions

- **DRUG:** Orlistat
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00001723
- **Lead sponsor:** Jack Yanovski
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-05
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2012-12-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001723, "Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00001723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*